JPMorgan
http://www.jpmorgan.comJPMorgan Chase & Co. (NYSE: JPM) is a leading global financial services firm with assets of $1.5 trillion and operations in more than 50 countries. The firm is a leader in investment banking, financial services for consumers, small business and commercial banking, financial transaction processing, asset management, and private equity.
-
-
-
-
-
-
-
JPM just refreshed its US Analyst Focus List, adding these 5 stocks
-
-
-
-
-
-
-
Ultragenyx to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
-
-
-
-
-
-
Ultragenyx Reports Preliminary 2022 Revenue; Guidance for 2023 Revenue and Cash Usage; Pipeline Updates and 2023 Milestones
-
-
-
-
-
-
-
Ultragenyx Reports Preliminary 2021 Revenue and 2022 Revenue Guidance for Crysvita® in Ultragenyx Territories* And Dojolvi® Globally; Provides Pipeline Updates and 2022 Milestones
-
-
-
-
-
-
-
Ultragenyx Reports Preliminary 2020 Revenue and 2021 Revenue Guidance for Crysvita in Ultragenyx Territories
-
-
-
-
-
-
-
Ultragenyx Announces Pricing of Public Offering of Common Stock
-
-
-
-
-
-
-
Ultragenyx to Present at 38ᵗʰ Annual J.P. Morgan Healthcare Conference
-
276,561 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

